Clinical trial
A Real-World Evidence, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of HPDT-DA-013 Digital Therapeutic in the Treatment of Major Depressive Disorder(MDD)and Generalized Anxiety Disorder(GAD)
NCT05016050 is registered in ClinicalTrials.gov with Happify Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Real-World Evidence, Single-Arm, Open-Label Study Evaluating the Safety and Efficacy of HPDT-DA-013 Digital Therapeutic in the Treatment of Major Depressive Disorder(MDD)and Generalized Anxiety Disorder(GAD)
- Lead sponsor
- Happify Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 9, 2021
- Completion date
- April 14, 2023
- Enrollment
- 367 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.